Literature DB >> 12166505

Continuing optic nerve atrophy following optic neuritis: a serial MRI study.

S J Hickman1, C M H Brierley, P A Brex, D G MacManus, N J Scolding, D A S Compston, D H Miller.   

Abstract

To investigate optic neuritis as a model for atrophy in multiple sclerosis (MS) lesions we performed serial magnetic resonance imaging (MRI) on 10 patients with a history of optic neuritis using a fat saturated short-echo fast fluid-attenuated inversion recovery (sTE fFLAIR) sequence. The first study was performed a median of 19.5 months after the onset of optic neuritis and the second 1 year later. Using a computer-assisted contouring technique, a blinded observer calculated the mean area of the intro-orbital optic nerves. The mean area of affected optic nerves decreased over 1 year by 0.9 mm2 from 11.1 to 10.2 mm2 (p = 0.01). Poor visual acuity and decreased visual-evoked potential (VEP) amplitude were associated with atrophy. These findings suggest that atrophy is a feature of focal demyelinating lesions, it may evolve over several years, and may have functional significance. Optic neuritis provides a model to study the effect of inflammatory demyelination through the ability to accurately measure visual function and to visualize and measure the optic nerves using magnetic resonance imaging.

Entities:  

Mesh:

Year:  2002        PMID: 12166505     DOI: 10.1191/1352458502ms809oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  20 in total

Review 1.  Loss of vision: imaging the visual pathways.

Authors:  H R Jäger
Journal:  Eur Radiol       Date:  2005-01-26       Impact factor: 5.315

Review 2.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

3.  Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

Authors:  Carmen Tur; Olivia Goodkin; Daniel R Altmann; Thomas M Jenkins; Katherine Miszkiel; Alessia Mirigliani; Camilla Fini; Claudia A M Gandini Wheeler-Kingshott; Alan J Thompson; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2016-02-17       Impact factor: 13.501

4.  Improved Automatic Optic Nerve Radius Estimation from High Resolution MRI.

Authors:  Robert L Harrigan; Alex K Smith; Louise A Mawn; Seth A Smith; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-24

5.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

Review 6.  MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms.

Authors:  N Passi; A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

7.  Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.

Authors:  L Leocani; M Rovaris; F M Boneschi; S Medaglini; P Rossi; V Martinelli; S Amadio; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-30       Impact factor: 10.154

Review 8.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

9.  Electronic Medical Record Context Signatures Improve Diagnostic Classification Using Medical Image Computing.

Authors:  Shikha Chaganti; Louise A Mawn; Hakmook Kang; Josephine Egan; Susan M Resnick; Lori L Beason-Held; Bennett A Landman; Thomas A Lasko
Journal:  IEEE J Biomed Health Inform       Date:  2018-12-28       Impact factor: 5.772

10.  Constructing a statistical atlas of the radii of the optic nerve and cerebrospinal fluid sheath in young healthy adults.

Authors:  Robert L Harrigan; Andrew J Plassard; Louise A Mawn; Robert L Galloway; Seth A Smith; Bennett A Landman
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.